{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:31:55Z","timestamp":1792812715931,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1245\/s10434-018-6660-x","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T21:37:56Z","timestamp":1533073076000},"page":"3341-3349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Baseline Neutrophil\u2013Lymphocyte and Platelet\u2013Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study"],"prefix":"10.1245","volume":"25","author":[{"given":"Ryckie G.","family":"Wade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyss V.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C. I.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Keeble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Marples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"Dewar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D. S.","family":"Moncrieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Peach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"6660_CR1","unstructured":"Cancer Research UK. Skin Cancer Statistics (Internet), 2015. Retrieved at \n                    http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/types\/skin\/\n                    \n                  . Accessed October 2017."},{"key":"6660_CR2","doi-asserted-by":"publisher","first-page":"h3708","DOI":"10.1136\/bmj.h3708","volume":"351","author":"F Macbeth","year":"2015","unstructured":"Macbeth F, Newton-Bishop J, O\u2019Connell S, et al. Melanoma: summary of NICE guidance. BMJ 2015;351:h3708.","journal-title":"BMJ"},{"key":"6660_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrc.2016.52","volume":"16","author":"SB Coffelt","year":"2016","unstructured":"Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer. 2016;16:431\u201346.","journal-title":"Nat Rev Cancer."},{"key":"6660_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12307-012-0123-x","volume":"6","author":"DM Richards","year":"2013","unstructured":"Richards DM, Hettinger J, Feuerer M. Monocytes and macrophages in cancer: development and functions. Cancer Microenviron. 2013;6:179\u201391.","journal-title":"Cancer Microenviron."},{"key":"6660_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11:123\u201334.","journal-title":"Nat Rev Cancer."},{"key":"6660_CR6","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","volume":"69","author":"I Ray-Coquard","year":"2009","unstructured":"Ray-Coquard I, Cropet C, Van Glabbeke M, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009;69:5383\u201391.","journal-title":"Cancer Res."},{"key":"6660_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. JNCI J Natl Cancer Inst. 2014;106:124.","journal-title":"JNCI J Natl Cancer Inst."},{"key":"6660_CR8","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1158\/1055-9965.EPI-14-0146","volume":"23","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, Ace O, McNamara MG, et al. Prognostic role of platelet-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Prev Biomarkers. 2014;23:1204\u201312.","journal-title":"Cancer Epidemiol Prev Biomarkers."},{"key":"6660_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ctrv.2015.10.003","volume":"41","author":"TF Nishijima","year":"2015","unstructured":"Nishijima TF, Muss HB, Shachar SS, Tamura K, Takamatsu Y. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41:971\u20138.","journal-title":"Cancer Treat Rev."},{"key":"6660_CR10","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1038\/bjc.2015.180","volume":"112","author":"PF Ferrucci","year":"2015","unstructured":"Ferrucci PF, Gandini S, Battaglia A, et al. Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients. Br J Cancer. 2015;112:1904\u201310.","journal-title":"Br J Cancer."},{"key":"6660_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/bjd.14155","volume":"174","author":"J Zaragoza","year":"2016","unstructured":"Zaragoza J, Caille A, Beneton N, et al. High neutrophil-to-lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma. Br J Dermatol. 2016;174:146\u201351.","journal-title":"Br J Dermatol."},{"key":"6660_CR12","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1002\/cam4.878","volume":"5","author":"L Khoja","year":"2016","unstructured":"Khoja L, Atenafu EG, Templeton A, et al. The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanoma. Cancer Med. 2016;5:2792\u20139.","journal-title":"Cancer Med."},{"key":"6660_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/CMR.0000000000000333","volume":"27","author":"LS Lino-Silva","year":"2017","unstructured":"Lino-Silva LS, Salcedo-Hern\u00e1ndez RA, Garc\u00eda-P\u00e9rez L, Meneses-Garc\u00eda A, Zepeda-Najar C. Basal neutrophil-to-lymphocyte ratio is associated with overall survival in melanoma. Melanoma Res. 2017;27:140\u20134.","journal-title":"Melanoma Res."},{"key":"6660_CR14","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1245\/s10434-017-5836-0","volume":"24","author":"JL Davis","year":"2017","unstructured":"Davis JL, Langan RC, Panageas KS, et al. Elevated blood neutrophil-to-lymphocyte ratio: a readily available biomarker associated with death due to disease in high-risk nonmetastatic melanoma. Ann Surg Oncol. 2017;24:1989\u201396.","journal-title":"Ann Surg Oncol."},{"key":"6660_CR15","volume-title":"AJCC Cancer Staging Manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL TA. AJCC Cancer Staging Manual. 7th ed. Springer New York, LLC, New York, NY, 2010.","edition":"7"},{"key":"6660_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/bjd.13675","volume":"172","author":"M Sladden","year":"2015","unstructured":"Sladden M, Zagarella S, Popescu C, Bigby M. No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial I\u2013final report. Br J Dermatol. 2015;172:566\u201371.","journal-title":"Br J Dermatol."},{"key":"6660_CR17","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1007\/s00268-013-2418-6","volume":"38","author":"FCM Cananzi","year":"2014","unstructured":"Cananzi FCM, Dalgleish A, Mudan S. Surgical management of intraabdominal metastases from melanoma: role of the neutrophil-to-lymphocyte ratio as a potential prognostic factor. World J Surg. 2014;38:1542\u201350.","journal-title":"World J Surg."},{"key":"6660_CR18","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/ijc.30215","volume":"139","author":"S Gandini","year":"2016","unstructured":"Gandini S, Ferrucci PF, Botteri E, et al. Prognostic significance of hematological profiles in melanoma patients. Int J Cancer. 2016;139:1618\u201325.","journal-title":"Int J Cancer."},{"key":"6660_CR19","doi-asserted-by":"publisher","first-page":"e51862","DOI":"10.1371\/journal.pone.0051862","volume":"7","author":"J Budczies","year":"2012","unstructured":"Budczies J, Klauschen F, Sinn B V, et al. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One. 2012;7:e51862.","journal-title":"PLoS One."},{"key":"6660_CR20","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162:W1\u201373.","journal-title":"Ann Intern Med."},{"key":"6660_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJK Guthrie","year":"2013","unstructured":"Guthrie GJK, Charles KA, Roxburgh CSD, et al. The systemic inflammation-based neutrophil\u2013lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218\u201330.","journal-title":"Crit Rev Oncol Hematol."},{"key":"6660_CR22","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2217\/bmm-2016-0147","volume":"10","author":"BD Lin","year":"2016","unstructured":"Lin BD, Hottenga J-J, Abdellaoui A, et al. Causes of variation in the neutrophil\u2013lymphocyte and platelet\u2013lymphocyte ratios: a twin-family study. Biomark Med. 2016;10:1061\u201372.","journal-title":"Biomark Med."},{"key":"6660_CR23","unstructured":"Newton Bishop JA. Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma. Retrieved at \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/N\n                    \n                  . Accessed October 2017."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6660-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6660-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6660-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T23:09:47Z","timestamp":1564528187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6660-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["6660"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6660-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"15 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}